Quarterly report pursuant to Section 13 or 15(d)

Equity Compensation Plan (Details Narrative)

v3.22.1
Equity Compensation Plan (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Feb. 09, 2022
Mar. 11, 2020
Dec. 30, 2021
Jun. 22, 2021
Sep. 22, 2020
Jul. 16, 2020
Mar. 26, 2020
Mar. 31, 2022
Mar. 31, 2021
Sep. 25, 2021
Sep. 22, 2021
Sep. 16, 2020
Sep. 15, 2020
Jun. 18, 2019
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Outstanding shares of common stock 5.00%                          
Stock-based compensation expense               $ 51,000 $ 678,000          
Unamortized stock-based compensation               $ 1,500,000            
Unamortized stock-based compensation period               2 years 3 months 18 days            
Intrinsic value of outstanding               $ 223,000            
Intrinsic value of vested stock options               155,000            
Research and Development Expense [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Stock-based compensation expense               7,000 3,000          
General and Administrative Expense [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Stock-based compensation expense               $ 44,000 643,000          
Cost of Sales [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Stock-based compensation expense                 $ 32,000          
Chief Executive Officer [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Unvested options                   25,000 1,911,160      
Options Held [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Option grant term     10 years                      
Option exercise price     $ 1.77                      
Option granted     445,000 388,246       2,886,129            
Equity Compensation Plan description   The grant was reduced to 500,000 options, including 375,000 options and 125,000 options respectively under the two categories, due to limitations under the 2019 Plan. The terms of the 125,000 performance-based options were established in the quarter ended December 31, 2021. The terms of the performance-based options were met during the quarter ended March 31, 2021.         the Board of Directors and a majority of the Company’s shareholders approved an amendment to the 2019 Plan to (i) increase the number of shares of common stock authorized for issuance under the 2019 Plan by 1,174,000 shares, such that a total of 2,500,000 shares of common stock are now authorized for issuance under the 2019 Plan; (ii) increase the maximum aggregate number of shares, options and/or other awards that may be granted to any one person during any calendar year from 500,000 to 1,300,000; and (iii) clarify the availability of cashless exercise as a form of consideration.              
Options Held [Member] | Minimum [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Option exercise price       $ 2.90                    
Options Held [Member] | Maximum [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Option exercise price       $ 3.93                    
Options Held [Member] | Executive Chairman [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Option grant term   10 years       10 years                
Option exercise price   $ 1.50       $ 1.50                
Option granted   965,850       600,000                
Options Held [Member] | Chief Executive Officer [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Option grant term         10 years                  
Option exercise price         $ 1.50                  
Option granted   321,950     1,637,410 200,000                
2019 Equity Compensation Plan                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Number of Shares Authorized 4,600,000                         1,326,000
Amended 2019 Equity Compensation Plan                            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                            
Number of Shares Authorized                       4,600,000 2,500,000